Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Anglo-Saxon eye remedy kills MRSA
Bald's Leechbook
Scientists recreated a 10th century potion for eye infections from Bald's Leechbook, an old medical textbook.
Researchers 'genuinely astonished'

An Anglo-Saxon remedy for eye infections could be the answer to killing the antibiotic superbug MRSA, according to research led by the University of Nottingham.

Scientists recreated a 10th century potion for eye infections from Bald's Leechbook, an old medical textbook in the British Library, to see if it really works as a remedy.

They were astonished to find that the 'potion', made of garlic, onion and parts of a cow's stomach, has remarkable effects on Methicillen-resistant Staphylococcus aureus (MRSA).

The team now has data showing that Bald's eye treatment kills up to 90 per cent of MRSA bacteria in 'in vivo' wound biopsies from mouse models.  

Anglo-Saxon expert Dr Christina Lee from the University of Nottingham translated the recipe for the eye salve, which contained garlic, onion, wine and oxgall (bile from a cow's stomach).

Experts from the University's microbiology team then duplicated the remedy and tested it on MRSA cultures both in synthetic wounds and in infected wounds in mice.  

Commenting on the study, Dr Lee said: “We were genuinely astonished at the results of our experiments in the lab. We believe modern research into disease can benefit from past responses and knowledge, which is largely contained in non-scientific writings. But the potential of these texts to contribute to addressing the challenges cannot be understood without the combined expertise of both the arts and science."

Microbiologist, Dr Freya Harrison added: “We thought that Bald’s eye salve might show a small amount of antibiotic activity, because each of the ingredients has been shown by other researchers to have some effect on bacteria in the lab – copper and bile salts can kill bacteria, and the garlic family of plants make chemicals that interfere with the bacteria’s ability to damage infected tissues.

"But we were absolutely blown away by just how effective the combination of ingredients was. We tested it in difficult conditions too; we let our artificial ‘infections’ grow into dense, mature populations called ‘biofilms’, where the individual cells bunch together and make a sticky coating that makes it hard for antibiotics to reach them. But unlike many modern antibiotics, Bald’s eye salve has the power to breach these defences.”

The team are due to present their findings at the Annual Conference for the Society for General Microbiology. 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.